Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Dr Frassoni's paper was shown to Dr Sue Richards, who has commented as follows

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bladé J, San Miguel JF, Fontanillas M et al. Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/autotransplantation and who were conventionally treated J Clin Oncol 1996 14: 2167–2173

    Article  Google Scholar 

  2. García-Carbonero R, Hidalgo M, Paz-Ares L et al. Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer J Clin Oncol 1997 15: 3178–3184

    Article  Google Scholar 

  3. Rahman ZU, Frye DK, Buzdar AU et al. Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer J Clin Oncol 1997 15: 3171–3177

    Article  CAS  Google Scholar 

  4. Berman E, Little C, Gee T et al. Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation New Engl J Med 1992 326: 156–160

    Article  CAS  Google Scholar 

  5. Coronary Drug Project Research Group . Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project New Engl J Med 1980 303: 1038–1041

    Article  Google Scholar 

  6. Gratwohl A, Hermans J, Goldman JM et al. for the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Risk assessment for patients with chronic leukaemia before allogeneic blood or marrow transplantation Lancet 1998 352: 1087–1092

    Article  CAS  Google Scholar 

  7. Rothwell PM, Warlow CP on behalf of the European Carotid Surgery Trialists’ Collaborative Group . Prediction of benefit from carotid endarterectomy in individual patients: a risk modelling study Lancet 1999 353: 2105–2110

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richards, S. Dr Frassoni's paper was shown to Dr Sue Richards, who has commented as follows. Bone Marrow Transplant 25, 472–473 (2000). https://doi.org/10.1038/sj.bmt.1702200

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702200

Search

Quick links